Drug therapy for chronic idiopathic axonal polyneuropathy (Q24247228)

Chronic idiopathic axonal polyneuropathy

Europe PubMed Central

title

Drug therapy for chronic idiopathic axonal polyneuropathy (English)

0 references

main subject

idiopathy

0 references

0 references

author

Nicolette C Notermans

4

object named as

Nicolette C Notermans

0 references

Alexander F J E Vrancken

1

object named as

Alexander FJE Vrancken

0 references

author name string

Ivo N van Schaik

2

0 references

Richard AC Hughes

Cochrane Database of Systematic Reviews

3

0 references

publication date

19 April 2004

0 references

published in

0 references

cites work

Double-blind controlled trials of Cronassial in chronic neuromuscular diseases and ataxia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

L-Acetylcarnitine in the Treatment of Patients with Peripheral Neuropathies : A Short Term, Double-Blind Clinical Study of 426 Patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Topical amitriptyline versus lidocaine in the treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Efficient assessment of neuropathic pain drugs in patients with small fiber sensory neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

The effect of Neuragen PN on neuropathic pain: A randomized, double blind, placebo controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Morphine responsiveness, efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Oral opioid therapy for chronic peripheral and central neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

St. John's wort has no effect on pain in polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Vitamin B for treating peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Unmyelinated nerve fiber degeneration in chronic inflammatory demyelinating polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Economic evaluation of oral treatments for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Systemic administration of local anesthetic agents to relieve neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Topical capsaicin for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Neuropathic pain: emerging treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Does impaired glucose metabolism cause polyneuropathy? Review of previous studies and design of a prospective controlled population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Opioids for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Hypertension as a risk factor for diabetic neuropathy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Prospective study of the usefulness of sural nerve biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Neuroregenerative and neuroprotective actions of neuroimmunophilin compounds in traumatic and inflammatory neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Clinimetric properties of a walking scale in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Prevalence of somatic small fiber neuropathy in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

The role of growth factors in diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Prostaglandin E1 for diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Duloxetine for treating painful neuropathy or chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Ion channel targets and treatment efficacy in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Chronic polyneuropathy of undetermined cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Naarden, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Alpha-lipoic acid for diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Rho kinase, a promising drug target for neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Chronic idiopathic axonal polyneuropathy: a five year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Diagnostic usefulness and limitations of the sural nerve biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Challenges in the development of novel treatment strategies for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Cerebral vascular accidents in patients over the age of 60. II. Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Clinical utilization and complications of sural nerve biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Rehabilitation interventions for foot drop in neuromuscular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Neurotrophic factors as novel therapeutics for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Challenges in the identification of cobalamin-deficiency polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Lifestyle intervention for pre-diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Impaired glucose tolerance and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Idiopathic neuropathy patients are at high risk for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Quality of life in patients with axonal polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Relationship between ischemia and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Thickness of endoneurial vessel basal lamina area in chronic idiopathic axonal polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Interobserver agreement for the assessment of handicap in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Progressive idiopathic axonal neuropathy--a comparative clinical and histopathological study with vasculitic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Exercise for people with peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Interventions for fatigue in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Lamotrigine for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

An Open and Double-Blind Cross-Over Study on the Efficacy of Clomipramine (Anafranil®) in Patients with Painful Mono- and Polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Role of insulin-like growth factor-I in the treatment of painful small fiber predominant neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

The yield of sural nerve biopsy in the evaluation of peripheral neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Malignancy and sensory neuropathy of unexplained cause: a prospective study of 51 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Intensive evaluation of referred unclassified neuropathies yields improved diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Pain in patients with chronic idiopathic axonal polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Cryptogenetic polyneuropathies: an out-patient follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Prospective follow-up study of chronic polyneuropathy of undetermined cause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Cryptogenic polyneuropathy: clinical and neurophysiological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Nerve conduction and biopsy correlation in over 100 consecutive patients with suspected polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Postoperative effects and value of sural nerve biopsies: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Chronic idiopathic axonal polyneuropathy and successful aging of the peripheral nervous system in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

Gabapentin for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Selective decrease in axonal nerve growth factor and insulin-like growth factor I immunoreactivity in axonopathies of unknown etiology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003456.PUB2